| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| RMD - ResMed Inc | HOLD | 0 @ USD 251.44 | USD 0 | The current share valuation price of RMD based on adjusted close was USD 251.44. The average price that RMD shares were previous bought at was USD 246.636. The current market price is 1.9% higher than average price they were purchased at. The value of the holding in RMD has increased by USD 42,964 compared to the previous valuation of ResMed Inc however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| IQV - IQVIA Holdings Inc | HOLD | 0 @ USD 227.24 | USD 0 | The current share valuation price of IQV based on adjusted close was USD 227.24. The average price that IQV shares were previous bought at was USD 193.922. The current market price is 17.2% higher than average price they were purchased at. The value of the holding in IQV has increased by USD 135,688 compared to the previous valuation of IQVIA Holdings Inc however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| ISRG - Intuitive Surgical Inc | HOLD | 0 @ USD 569.71 | USD 0 | The current share valuation price of ISRG based on adjusted close was USD 569.71. The average price that ISRG shares were previous bought at was USD 523.887. The current market price is 8.7% higher than average price they were purchased at. The value of the holding in ISRG has increased by USD 353,864 compared to the previous valuation of Intuitive Surgical Inc however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| JNJ - Johnson & Johnson | HOLD | 0 @ USD 205.33 | USD 0 | The current share valuation price of JNJ based on adjusted close was USD 205.33. The average price that JNJ shares were previous bought at was USD 169.608. The current market price is 21.1% higher than average price they were purchased at. The value of the holding in JNJ has fallen by USD 107,485 compared to the previous valuation of Johnson & Johnson |
| LH - Laboratory Corporation of America Holdings | HOLD | 0 @ USD 265.76 | USD 0 | The current share valuation price of LH based on adjusted close was USD 265.76. The average price that LH shares were previous bought at was USD 254.641. The current market price is 4.4% higher than average price they were purchased at. The value of the holding in LH has fallen by USD 7,027 compared to the previous valuation of Laboratory Corporation of America Holdings |
| LLY - Eli Lilly and Company | HOLD | 0 @ USD 1033.56 | USD 0 | The current share valuation price of LLY based on adjusted close was USD 1033.56. The average price that LLY shares were previous bought at was USD 844.311. The current market price is 22.4% higher than average price they were purchased at. The value of the holding in LLY has fallen by USD 4,951,378 compared to the previous valuation of Eli Lilly and Company |
| MCK - McKesson Corporation | HOLD | 0 @ USD 805.37 | USD 0 | The current share valuation price of MCK based on adjusted close was USD 805.37. The average price that MCK shares were previous bought at was USD 701.29. The current market price is 14.8% higher than average price they were purchased at. The value of the holding in MCK has fallen by USD 1,500,650 compared to the previous valuation of McKesson Corporation |
| MDT - Medtronic PLC | HOLD | 0 @ USD 101.97 | USD 0 | The current share valuation price of MDT based on adjusted close was USD 101.97. The average price that MDT shares were previous bought at was USD 91.2503. The current market price is 11.7% higher than average price they were purchased at. The value of the holding in MDT has fallen by USD 38,118 compared to the previous valuation of Medtronic PLC |
| MOH - MOH | HOLD | 0 @ USD 149.09 | USD 0 | The current share valuation price of MOH based on adjusted close was USD 149.09. The average price that MOH shares were previous bought at was USD 253.075. The current market price is -41.1% lower than average price they were purchased at. The value of the holding in MOH has increased by USD 84,449 compared to the previous valuation of MOH however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | HOLD | 0 @ USD 149.09 | USD 0 | The current share valuation price of MOH based on adjusted close was USD 149.09. The average price that MOH shares were previous bought at was USD 253.075. The current market price is -41.1% lower than average price they were purchased at. The value of the holding in MOH has increased by USD 84,449 compared to the previous valuation of LVMH Moët Hennessy - Louis Vuitton Société Européenne however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| MRK - Marks Electrical Group PLC | HOLD | 0 @ USD 102.27 | USD 0 | The current share valuation price of MRK based on adjusted close was USD 102.27. The average price that MRK shares were previous bought at was USD 89.997. The current market price is 13.6% higher than average price they were purchased at. The value of the holding in MRK has increased by USD 1,536,272 compared to the previous valuation of Marks Electrical Group PLC however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| MRK - Merck & Company Inc | HOLD | 0 @ USD 102.27 | USD 0 | The current share valuation price of MRK based on adjusted close was USD 102.27. The average price that MRK shares were previous bought at was USD 89.997. The current market price is 13.6% higher than average price they were purchased at. The value of the holding in MRK has increased by USD 1,536,272 compared to the previous valuation of Merck & Company Inc however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| MRNA - Moderna Inc | HOLD | 0 @ USD 25.18 | USD 0 | The current share valuation price of MRNA based on adjusted close was USD 25.18. The average price that MRNA shares were previous bought at was USD 31.1562. The current market price is -19.2% lower than average price they were purchased at. The value of the holding in MRNA has increased by USD 191,270 compared to the previous valuation of Moderna Inc however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| MTD - Mettler-Toledo International Inc | HOLD | 0 @ USD 1434.88 | USD 0 | The current share valuation price of MTD based on adjusted close was USD 1434.88. The average price that MTD shares were previous bought at was USD 1287.99. The current market price is 11.4% higher than average price they were purchased at. The value of the holding in MTD has fallen by USD 126,251 compared to the previous valuation of Mettler-Toledo International Inc |
| MTD - AMUNDI EUR GOV 710 | HOLD | 0 @ USD 1434.88 | USD 0 | The current share valuation price of MTD based on adjusted close was USD 1434.88. The average price that MTD shares were previous bought at was USD 1287.99. The current market price is 11.4% higher than average price they were purchased at. The value of the holding in MTD has fallen by USD 126,251 compared to the previous valuation of AMUNDI EUR GOV 710 |
| PFE - Pfizer Inc | HOLD | 0 @ USD 25.57 | USD 0 | The current share valuation price of PFE based on adjusted close was USD 25.57. The average price that PFE shares were previous bought at was USD 25.3617. The current market price is 0.8% higher than average price they were purchased at. The value of the holding in PFE has increased by USD 1,185,557 compared to the previous valuation of Pfizer Inc however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| PODD - Insulet Corporation | HOLD | 0 @ USD 307.56 | USD 0 | The current share valuation price of PODD based on adjusted close was USD 307.56. The average price that PODD shares were previous bought at was USD 292.021. The current market price is 5.3% higher than average price they were purchased at. The value of the holding in PODD has fallen by USD 50,082 compared to the previous valuation of Insulet Corporation |
| REGN - Regeneron Pharmaceuticals Inc | HOLD | 0 @ USD 723.67 | USD 0 | The current share valuation price of REGN based on adjusted close was USD 723.67. The average price that REGN shares were previous bought at was USD 664.262. The current market price is 8.9% higher than average price they were purchased at. The value of the holding in REGN has fallen by USD 926,197 compared to the previous valuation of Regeneron Pharmaceuticals Inc |
| INCY - Incyte Corporation | HOLD | 0 @ USD 101.5 | USD 0 | The current share valuation price of INCY based on adjusted close was USD 101.5. The average price that INCY shares were previous bought at was USD 78.4776. The current market price is 29.3% higher than average price they were purchased at. The value of the holding in INCY has increased by USD 4,909 compared to the previous valuation of Incyte Corporation however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| RVTY - Revvity Inc. | HOLD | 0 @ USD 103.26 | USD 0 | The current share valuation price of RVTY based on adjusted close was USD 103.26. The average price that RVTY shares were previous bought at was USD 105.147. The current market price is -1.8% lower than average price they were purchased at. The value of the holding in RVTY has increased by USD 30,871 compared to the previous valuation of Revvity Inc. however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| SOLV - Solventum Corp. | HOLD | 0 @ USD 85.25 | USD 0 | The current share valuation price of SOLV based on adjusted close was USD 85.25. The average price that SOLV shares were previous bought at was USD 74.1326. The current market price is 15.0% higher than average price they were purchased at. The value of the holding in SOLV has fallen by USD 24,725 compared to the previous valuation of Solventum Corp. |
| STE - STERIS plc | HOLD | 0 @ USD 259.4 | USD 0 | The current share valuation price of STE based on adjusted close was USD 259.4. The average price that STE shares were previous bought at was USD 233.049. The current market price is 11.3% higher than average price they were purchased at. The value of the holding in STE has increased by USD 4,842 compared to the previous valuation of STERIS plc however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| SYK - Stryker Corporation | HOLD | 0 @ USD 365.95 | USD 0 | The current share valuation price of SYK based on adjusted close was USD 365.95. The average price that SYK shares were previous bought at was USD 375.395. The current market price is -2.5% lower than average price they were purchased at. The value of the holding in SYK has fallen by USD 124,701 compared to the previous valuation of Stryker Corporation |
| TECH - Bio-Techne Corp | HOLD | 0 @ USD 63.82 | USD 0 | The current share valuation price of TECH based on adjusted close was USD 63.82. The average price that TECH shares were previous bought at was USD 62.3914. The current market price is 2.3% higher than average price they were purchased at. The value of the holding in TECH has increased by USD 67,285 compared to the previous valuation of Bio-Techne Corp however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| TMO - Time Out Group plc | HOLD | 0 @ USD 580.45 | USD 0 | The current share valuation price of TMO based on adjusted close was USD 580.45. The average price that TMO shares were previous bought at was USD 522.412. The current market price is 11.1% higher than average price they were purchased at. The value of the holding in TMO has increased by USD 14,983 compared to the previous valuation of Time Out Group plc however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| UHS - Universal Health Services Inc | HOLD | 0 @ USD 230.15 | USD 0 | The current share valuation price of UHS based on adjusted close was USD 230.15. The average price that UHS shares were previous bought at was USD 197.686. The current market price is 16.4% higher than average price they were purchased at. The value of the holding in UHS has fallen by USD 241,552 compared to the previous valuation of Universal Health Services Inc |
| UNH - UnitedHealth Group Incorporated | HOLD | 0 @ USD 339.71 | USD 0 | The current share valuation price of UNH based on adjusted close was USD 339.71. The average price that UNH shares were previous bought at was USD 434.856. The current market price is -21.9% lower than average price they were purchased at. The value of the holding in UNH has increased by USD 6,809,889 compared to the previous valuation of UnitedHealth Group Incorporated however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| VRTX - Vertex Pharmaceuticals Inc | HOLD | 0 @ USD 463.13 | USD 0 | The current share valuation price of VRTX based on adjusted close was USD 463.13. The average price that VRTX shares were previous bought at was USD 446.865. The current market price is 3.6% higher than average price they were purchased at. The value of the holding in VRTX has increased by USD 3,816,244 compared to the previous valuation of Vertex Pharmaceuticals Inc however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| VTRS - Viatris Inc | HOLD | 0 @ USD 10.84 | USD 0 | The current share valuation price of VTRS based on adjusted close was USD 10.84. The average price that VTRS shares were previous bought at was USD 10.2561. The current market price is 5.7% higher than average price they were purchased at. The value of the holding in VTRS has increased by USD 74,320 compared to the previous valuation of Viatris Inc however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| WAT - Waters Corporation | HOLD | 0 @ USD 397.62 | USD 0 | The current share valuation price of WAT based on adjusted close was USD 397.62. The average price that WAT shares were previous bought at was USD 360.014. The current market price is 10.4% higher than average price they were purchased at. The value of the holding in WAT has fallen by USD 29,408 compared to the previous valuation of Waters Corporation |
| WAT - MULETFWATIMETFP | HOLD | 0 @ USD 397.62 | USD 0 | The current share valuation price of WAT based on adjusted close was USD 397.62. The average price that WAT shares were previous bought at was USD 360.014. The current market price is 10.4% higher than average price they were purchased at. The value of the holding in WAT has fallen by USD 29,408 compared to the previous valuation of MULETFWATIMETFP |
| WST - West Pharmaceutical Services Inc | HOLD | 0 @ USD 284.31 | USD 0 | The current share valuation price of WST based on adjusted close was USD 284.31. The average price that WST shares were previous bought at was USD 260.885. The current market price is 9.0% higher than average price they were purchased at. The value of the holding in WST has increased by USD 399,436 compared to the previous valuation of West Pharmaceutical Services Inc however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| ZBH - Zimmer Biomet Holdings Inc | HOLD | 0 @ USD 93.1 | USD 0 | The current share valuation price of ZBH based on adjusted close was USD 93.1. The average price that ZBH shares were previous bought at was USD 102.119. The current market price is -8.8% lower than average price they were purchased at. The value of the holding in ZBH has fallen by USD 102,383 compared to the previous valuation of Zimmer Biomet Holdings Inc |
| ZTS - Zoetis Inc | HOLD | 0 @ USD 122.57 | USD 0 | The current share valuation price of ZTS based on adjusted close was USD 122.57. The average price that ZTS shares were previous bought at was USD 154.809. The current market price is -20.8% lower than average price they were purchased at. The value of the holding in ZTS has fallen by USD 412,451 compared to the previous valuation of Zoetis Inc |
| CRL - Creightons Plc | HOLD | 0 @ USD 184.67 | USD 0 | The current share valuation price of CRL based on adjusted close was USD 184.67. The average price that CRL shares were previous bought at was USD 167.983. The current market price is 9.9% higher than average price they were purchased at. The value of the holding in CRL has increased by USD 240,556 compared to the previous valuation of Creightons Plc however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| ABBV - AbbVie Inc | HOLD | 0 @ USD 230.24 | USD 0 | The current share valuation price of ABBV based on adjusted close was USD 230.24. The average price that ABBV shares were previous bought at was USD 204.216. The current market price is 12.7% higher than average price they were purchased at. The value of the holding in ABBV has increased by USD 5,142,472 compared to the previous valuation of AbbVie Inc however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| ABT - Abbott Laboratories | HOLD | 0 @ USD 125.29 | USD 0 | The current share valuation price of ABT based on adjusted close was USD 125.29. The average price that ABT shares were previous bought at was USD 128.328. The current market price is -2.4% lower than average price they were purchased at. The value of the holding in ABT has fallen by USD 889,186 compared to the previous valuation of Abbott Laboratories |
| ALGN - Align Technology Inc | HOLD | 0 @ USD 155 | USD 0 | The current share valuation price of ALGN based on adjusted close was USD 155. The average price that ALGN shares were previous bought at was USD 171.385. The current market price is -9.6% lower than average price they were purchased at. The value of the holding in ALGN has increased by USD 136,984 compared to the previous valuation of Align Technology Inc however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| AMGN - Amgen Inc | HOLD | 0 @ USD 345.42 | USD 0 | The current share valuation price of AMGN based on adjusted close was USD 345.42. The average price that AMGN shares were previous bought at was USD 302.719. The current market price is 14.1% higher than average price they were purchased at. The value of the holding in AMGN has increased by USD 1,885,063 compared to the previous valuation of Amgen Inc however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| BAX - Baxter International Inc | HOLD | 0 @ USD 18.89 | USD 0 | The current share valuation price of BAX based on adjusted close was USD 18.89. The average price that BAX shares were previous bought at was USD 28.4174. The current market price is -33.5% lower than average price they were purchased at. The value of the holding in BAX has increased by USD 12,751 compared to the previous valuation of Baxter International Inc however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| BDX - Becton Dickinson and Company | HOLD | 0 @ USD 193.57 | USD 0 | The current share valuation price of BDX based on adjusted close was USD 193.57. The average price that BDX shares were previous bought at was USD 207.959. The current market price is -6.9% lower than average price they were purchased at. The value of the holding in BDX has increased by USD 440,125 compared to the previous valuation of Becton Dickinson and Company however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| BIIB - Biogen Inc | HOLD | 0 @ USD 180.75 | USD 0 | The current share valuation price of BIIB based on adjusted close was USD 180.75. The average price that BIIB shares were previous bought at was USD 146.535. The current market price is 23.3% higher than average price they were purchased at. The value of the holding in BIIB has increased by USD 41,428 compared to the previous valuation of Biogen Inc however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| BMY - Bloomsbury Publishing Plc | HOLD | 0 @ USD 50.96 | USD 0 | The current share valuation price of BMY based on adjusted close was USD 50.96. The average price that BMY shares were previous bought at was USD 52.039. The current market price is -2.1% lower than average price they were purchased at. The value of the holding in BMY has increased by USD 2,733,734 compared to the previous valuation of Bloomsbury Publishing Plc however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| BSX - Boston Scientific Corporation | HOLD | 0 @ USD 98.57 | USD 0 | The current share valuation price of BSX based on adjusted close was USD 98.57. The average price that BSX shares were previous bought at was USD 99.4294. The current market price is -0.9% lower than average price they were purchased at. The value of the holding in BSX has fallen by USD 330,733 compared to the previous valuation of Boston Scientific Corporation |
| BSX - MULSTRXSSXIMETFP | HOLD | 0 @ USD 98.57 | USD 0 | The current share valuation price of BSX based on adjusted close was USD 98.57. The average price that BSX shares were previous bought at was USD 99.4294. The current market price is -0.9% lower than average price they were purchased at. The value of the holding in BSX has fallen by USD 330,733 compared to the previous valuation of MULSTRXSSXIMETFP |
| CAH - Cardinal Health Inc | HOLD | 0 @ USD 199.71 | USD 0 | The current share valuation price of CAH based on adjusted close was USD 199.71. The average price that CAH shares were previous bought at was USD 148.95. The current market price is 34.1% higher than average price they were purchased at. The value of the holding in CAH has fallen by USD 638,411 compared to the previous valuation of Cardinal Health Inc |
| CI - Cigna Corp | HOLD | 0 @ USD 270.32 | USD 0 | The current share valuation price of CI based on adjusted close was USD 270.32. The average price that CI shares were previous bought at was USD 301.908. The current market price is -10.5% lower than average price they were purchased at. The value of the holding in CI has fallen by USD 501,361 compared to the previous valuation of Cigna Corp |
| CNC - Concurrent Technologies Plc | HOLD | 0 @ USD 38.81 | USD 0 | The current share valuation price of CNC based on adjusted close was USD 38.81. The average price that CNC shares were previous bought at was USD 50.8192. The current market price is -23.6% lower than average price they were purchased at. USD 0 compared to the previous valuation of Concurrent Technologies Plc however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| COO - The Cooper Companies, Inc. Common Stock | HOLD | 0 @ USD 75.98 | USD 0 | The current share valuation price of COO based on adjusted close was USD 75.98. The average price that COO shares were previous bought at was USD 81.8467. The current market price is -7.2% lower than average price they were purchased at. The value of the holding in COO has increased by USD 13,852 compared to the previous valuation of The Cooper Companies, Inc. Common Stock however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| COR - Cencora Inc. | HOLD | 0 @ USD 335.31 | USD 0 | The current share valuation price of COR based on adjusted close was USD 335.31. The average price that COR shares were previous bought at was USD 298.046. The current market price is 12.5% higher than average price they were purchased at. The value of the holding in COR has fallen by USD 1,476,649 compared to the previous valuation of Cencora Inc. |
| A - Agilent Technologies Inc | HOLD | 0 @ USD 149.26 | USD 0 | The current share valuation price of A based on adjusted close was USD 149.26. The average price that A shares were previous bought at was USD 133.072. The current market price is 12.2% higher than average price they were purchased at. The value of the holding in A has increased by USD 63,460 compared to the previous valuation of Agilent Technologies Inc however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| CVS - CVS Health Corp | HOLD | 0 @ USD 75 | USD 0 | The current share valuation price of CVS based on adjusted close was USD 75. The average price that CVS shares were previous bought at was USD 68.9571. The current market price is 8.8% higher than average price they were purchased at. The value of the holding in CVS has fallen by USD 1,647,715 compared to the previous valuation of CVS Health Corp |
| DGX - Quest Diagnostics Incorporated | HOLD | 0 @ USD 182.61 | USD 0 | The current share valuation price of DGX based on adjusted close was USD 182.61. The average price that DGX shares were previous bought at was USD 173.599. The current market price is 5.2% higher than average price they were purchased at. The value of the holding in DGX has increased by USD 3,289 compared to the previous valuation of Quest Diagnostics Incorporated however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| DHR - Danaher Corporation | HOLD | 0 @ USD 228.46 | USD 0 | The current share valuation price of DHR based on adjusted close was USD 228.46. The average price that DHR shares were previous bought at was USD 214.347. The current market price is 6.6% higher than average price they were purchased at. The value of the holding in DHR has increased by USD 589,961 compared to the previous valuation of Danaher Corporation however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| DHR - Danaher Corporation | HOLD | 0 @ USD 228.46 | USD 0 | The current share valuation price of DHR based on adjusted close was USD 228.46. The average price that DHR shares were previous bought at was USD 214.347. The current market price is 6.6% higher than average price they were purchased at. The value of the holding in DHR has increased by USD 589,961 compared to the previous valuation of Danaher Corporation however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| DVA - DaVita HealthCare Partners Inc | HOLD | 0 @ USD 118.25 | USD 0 | The current share valuation price of DVA based on adjusted close was USD 118.25. The average price that DVA shares were previous bought at was USD 143.535. The current market price is -17.6% lower than average price they were purchased at. The value of the holding in DVA has fallen by USD 16,500 compared to the previous valuation of DaVita HealthCare Partners Inc |
| DXCM - DexCom Inc | HOLD | 0 @ USD 64.85 | USD 0 | The current share valuation price of DXCM based on adjusted close was USD 64.85. The average price that DXCM shares were previous bought at was USD 73.4548. The current market price is -11.7% lower than average price they were purchased at. The value of the holding in DXCM has increased by USD 77,881 compared to the previous valuation of DexCom Inc however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| ELV - Elevance Health Inc | HOLD | 0 @ USD 330.75 | USD 0 | The current share valuation price of ELV based on adjusted close was USD 330.75. The average price that ELV shares were previous bought at was USD 375.554. The current market price is -11.9% lower than average price they were purchased at. The value of the holding in ELV has fallen by USD 18,967 compared to the previous valuation of Elevance Health Inc |
| ELV - Elevance Health Inc | HOLD | 0 @ USD 330.75 | USD 0 | The current share valuation price of ELV based on adjusted close was USD 330.75. The average price that ELV shares were previous bought at was USD 375.554. The current market price is -11.9% lower than average price they were purchased at. The value of the holding in ELV has fallen by USD 18,967 compared to the previous valuation of Elevance Health Inc |
| EW - Edwards Lifesciences Corp | HOLD | 0 @ USD 83.98 | USD 0 | The current share valuation price of EW based on adjusted close was USD 83.98. The average price that EW shares were previous bought at was USD 74.5534. The current market price is 12.6% higher than average price they were purchased at. The value of the holding in EW has fallen by USD 212,956 compared to the previous valuation of Edwards Lifesciences Corp |
| GEHC - GE HealthCare Technologies Inc. | HOLD | 0 @ USD 83.59 | USD 0 | The current share valuation price of GEHC based on adjusted close was USD 83.59. The average price that GEHC shares were previous bought at was USD 79.8893. The current market price is 4.6% higher than average price they were purchased at. The value of the holding in GEHC has increased by USD 761,974 compared to the previous valuation of GE HealthCare Technologies Inc. however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| GILD - Guild Esports Plc | HOLD | 0 @ USD 125 | USD 0 | The current share valuation price of GILD based on adjusted close was USD 125. The average price that GILD shares were previous bought at was USD 109.187. The current market price is 14.5% higher than average price they were purchased at. The value of the holding in GILD has increased by USD 671,202 compared to the previous valuation of Guild Esports Plc however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| HCA - HCA Holdings Inc | HOLD | 0 @ USD 486.77 | USD 0 | The current share valuation price of HCA based on adjusted close was USD 486.77. The average price that HCA shares were previous bought at was USD 382.797. The current market price is 27.2% higher than average price they were purchased at. The value of the holding in HCA has fallen by USD 1,099,949 compared to the previous valuation of HCA Holdings Inc |
| HOLX - Hologic Inc | HOLD | 0 @ USD 75.01 | USD 0 | The current share valuation price of HOLX based on adjusted close was USD 75.01. The average price that HOLX shares were previous bought at was USD 68.2129. The current market price is 10.0% higher than average price they were purchased at. The value of the holding in HOLX has increased by USD 20,889 compared to the previous valuation of Hologic Inc however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| HSIC - Henry Schein Inc | HOLD | 0 @ USD 72.88 | USD 0 | The current share valuation price of HSIC based on adjusted close was USD 72.88. The average price that HSIC shares were previous bought at was USD 71.1823. The current market price is 2.4% higher than average price they were purchased at. The value of the holding in HSIC has increased by USD 61,902 compared to the previous valuation of Henry Schein Inc however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| HUM - Hummingbird Resources PLC | HOLD | 0 @ USD 256.92 | USD 0 | The current share valuation price of HUM based on adjusted close was USD 256.92. The average price that HUM shares were previous bought at was USD 262.534. The current market price is -2.1% lower than average price they were purchased at. The value of the holding in HUM has increased by USD 891,421 compared to the previous valuation of Hummingbird Resources PLC however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| HUM - Humana Inc | HOLD | 0 @ USD 256.92 | USD 0 | The current share valuation price of HUM based on adjusted close was USD 256.92. The average price that HUM shares were previous bought at was USD 262.534. The current market price is -2.1% lower than average price they were purchased at. The value of the holding in HUM has increased by USD 891,421 compared to the previous valuation of Humana Inc however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| IDXX - IDEXX Laboratories Inc | HOLD | 0 @ USD 725.93 | USD 0 | The current share valuation price of IDXX based on adjusted close was USD 725.93. The average price that IDXX shares were previous bought at was USD 534.488. The current market price is 35.8% higher than average price they were purchased at. The value of the holding in IDXX has fallen by USD 269,063 compared to the previous valuation of IDEXX Laboratories Inc |